If one were to go back to previous messages left by me a few weeks ago, one would certainly notice that even though I was somewhat correct in predicting the deal between ULGX and EDAPY. (Although I must admit I thought it would be a complete sale of EDAPY to ULGX) Here is my opinion after the deal. There a a couple of things I would want to mention now. 1st EDAPY needed some cash, as you might now there was a possibility of delisting the company from NASDAQ, 2nd they still have a couple of interesting products in the pipeline they apperently wish to explore further. Especialy the treatment of tumors. I think the sale of the product line makes sense. It was not easy to compete with ULGX and there are drugs (that can be taken oraly) that shrink enlargements as well. So if you need cash and want to make competitor a friend...the deal looks OK. I think the stock migh have a chance to recover to about 1 3/4 or 2 a share sometime soon. As before I say, "Of course, that's just my opinion and I could be wrong" !!!